Rafet Basar

11PUBLICATIONS

94CO-AUTHORS

NanoelectronicsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (11)

Sort by Publication Date:

|Jun 12, 2026

Outsmarting NK surveillance: engineering stealth CAR T cells.

|Apr 22, 2026

CAR-NK cell therapy for hematological malignancies.

|Feb 11, 2026

Agent-based modeling of cellular dynamics in adoptive cell therapy.

Yujia Wang, Stefano Casarin, May Daher

|Oct 27, 2025

CD70-Targeting CAR NK Cells Overcome BCMA Downregulation and Improve Survival in High-risk Multiple Myeloma Models.

Paul Lin, Sunil Acharya, Francia Reyes-Silva

|Jun 26, 2025

Author Correction: Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial.

Yago Nieto, Pinaki Banerjee, Indreshpal Kaur

|Jun 04, 2025

CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells.

Hind Rafei, Rafet Basar, Sunil Acharya

Pageof 2

Frequent Collaborators

Katayoun Rezvani

May Daher

Hind Rafei

Vakul Mohanty

Ken Chen

Ye Li

Mayra Shanley

Mecit Kaplan

Sunil Acharya

Elizabeth J Shpall

Frequent Collaborators

Katayoun Rezvani

May Daher

Hind Rafei

Vakul Mohanty